BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9455828)

  • 41. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.
    Wood JR; Ho CK; Nelson-Degrave VL; McAllister JM; Strauss JF
    J Reprod Immunol; 2004 Aug; 63(1):51-60. PubMed ID: 15284005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotype and genotype in polycystic ovary syndrome.
    Legro RS; Spielman R; Urbanek M; Driscoll D; Strauss JF; Dunaif A
    Recent Prog Horm Res; 1998; 53():217-56. PubMed ID: 9769710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review.
    Reis GV; Gontijo NA; Rodrigues KF; Alves MT; Ferreira CN; Gomes KB
    J Obstet Gynaecol Res; 2017 Mar; 43(3):436-446. PubMed ID: 28127831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of insulin gene variable number of tandem repeats regulatory polymorphism with polycystic ovary syndrome.
    Yan MS; Liang GY; Xia BR; Liu DY; Kong D; Jin XM
    Hum Immunol; 2014 Oct; 75(10):1047-52. PubMed ID: 25220536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of genetic and environmental factors in the development of polycystic ovary syndrome].
    Ságodi L; Kiss-Tóth E; Barkai L
    Orv Hetil; 2013 Apr; 154(17):650-7. PubMed ID: 23608312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is foetal hyperexposure to androgens a cause of PCOS?
    Filippou P; Homburg R
    Hum Reprod Update; 2017 Jul; 23(4):421-432. PubMed ID: 28531286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on the mode of inheritance for familial polycystic ovary syndrome].
    Mao W; Li M; Chen Y; Lu C; Wang Y; Zhang X; Qiao J; Wang A
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Feb; 18(1):21-3. PubMed ID: 11172636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.
    Pusalkar M; Meherji P; Gokral J; Chinnaraj S; Maitra A
    Fertil Steril; 2009 Aug; 92(2):653-9. PubMed ID: 18725155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathomechanisms of polycystic ovary syndrome: Multidimensional approaches.
    Sagvekar P; Dadachanji R; Patil K; Mukherjee S
    Front Biosci (Elite Ed); 2018 Mar; 10(3):384-422. PubMed ID: 29293465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The existence of a male equivalent of the polycystic ovary syndrome--the present state of the issue.
    Dusková M; Stárka L
    Prague Med Rep; 2006; 107(1):17-25. PubMed ID: 16752800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome.
    Liu Y; Jiang H; He LY; Huang WJ; He XY; Xing FQ
    Reprod Fertil Dev; 2011; 23(4):520-6. PubMed ID: 21557918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
    Xita N; Tsatsoulis A
    J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Polymorphism of CYP11A1 gene in Chinese patients with polycystic ovarian syndrome].
    Gao GH; Cao YX; Yi L; Wei ZL; Xu YP; Yang C
    Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):191-6. PubMed ID: 20450755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN; Schulte N; Sonntag B; Kiesel L
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Looking for polycystic ovary syndrome genes: rational and best strategy.
    Goodarzi MO
    Semin Reprod Med; 2008 Jan; 26(1):5-13. PubMed ID: 18181077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.